NAMSNEWAMSTERDAM PHARMA CO NV
CUSIP N62509109 · common stock
5 tracked investors held NEWAMSTERDAM PHARMA CO NV (NAMS) at the end of Q3 2026, worth $421.8M in total. The largest holder was RA Capital Management, with 2.3% of its portfolio. Ron Baron sold out of its position this quarter.
Holders · Q3 2026
5
New holders
0
Value held
$421.8M
Quarter-end price (est.)
$24.32
Investors holding NAMS · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| RA Capital Management RA Capital Management, L.P. | 2.33% | 9,550,191 | $232.3M | HOLD |
| Stanley Druckenmiller Duquesne Family Office LLC | 1.83% | 3,357,146 | $81.6M | ADD+9.3% |
| Andreas Halvorsen Viking Global Investors LP | 0.18% | 2,463,911 | $59.9M | REDUCE-41.4% |
| Lee Ainslie Maverick Capital Ltd | 0.35% | 1,855,630 | $45.1M | REDUCE-43.2% |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.12% | 118,623 | $2.9M | HOLD |
Options
| Investor | Type | Underlying shares | Value | Change |
|---|---|---|---|---|
| Perceptive Advisors | Put | 600,000 | $14.6M | ADD+20.0% |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Ron Baron | 0.00% | 9,000 | $305K | EXIT |